Mechanisms of Cellular Transformation by HTLV-1 TAX

HTLV-1 TAX 的细胞转化机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): Human T-cell leukemia virus type I (HTLV-I) is the etiologic agent of adult T cell leukemia (ATL), an aggressive clonal malignancy of CD4+ T cells. HTLV-I encodes a regulatory protein, Tax, which is responsible for the transforming potential of HTLV-I. Although the precise mechanism remains unknown, Tax transformation depends upon its ability to activate cellular growth regulatory genes, and to modulate cellular signaling pathways. We have recently demonstrated that Tax stimulates cell cycle progression through G1 phase, suppresses DNA repair, and interferes with the DNA damage-induced G1/S checkpoint. These functions allow Tax-expressing cells to enter S phase and initiate DNA replication prior to the completion of DNA repair, creating an environment that promotes the fixation of DNA mutations into the host genome. Transformed lymphocytes isolated from ATL patients as well as Tax expressing cell lines display a variety of genomic abnormalities that are consistent with this activity. Together, these observations provide an intriguing model for Tax-mediated transformation, which will be further investigated through this renewal application. The overall hypothesis for these studies is that Tax-expressing cells fail to maintain the G1/S DNA damage induced checkpoint, thereby increasing the cellular mutation frequency and enhancing the potential for cellular transformation. The specific aims of this application are: (1) To determine the mechanism by which Tax allows bypass of the G1/S DNA damage induced cell cycle checkpoint. (2) To determine the consequences of S phase entry in the presence of DNA damage. (3) To determine the effect of Tax on mutation frequency and cellular transformation. The results of these studies will define critical steps in the specific process of HTLV-I transformation and are likely to provide broader insights into mechanisms of cellular proliferation and transformation.
描述(由申请人提供):人类T细胞白血病病毒I型(HTLV-I)是成年T细胞白血病(ATL)的病因,这是CD4+ T细胞的侵略性克隆恶性肿瘤。 HTLV-I编码一种调节蛋白,税收,该蛋白质负责HTLV-I的转化潜力。尽管确切机制仍然未知,但税收转化取决于其激活细胞生长调节基因的能力,并调节细胞信号通路。我们最近证明,税收刺激细胞周期通过G1相,抑制DNA修复,并干扰DNA损伤诱导的G1/S检查点。这些功能使表达税收的细胞可以进入S相并在DNA修复完成之前启动DNA复制,从而创造了一种环境,从而促进了DNA突变固定在宿主基因组中。从ATL患者中分离出来的转化的淋巴细胞以及表达细胞系的税收表现出与该活性一致的多种基因组异常。总之,这些观察结果为税收介导的转型提供了一个有趣的模型,将通过此续签应用进一步研究。这些研究的总体假设是,表达税收的细胞无法维持G1/S DNA损伤引起的检查点,从而增加了细胞突变频率并增强了细胞转化的潜力。该应用程序的具体目的是:(1)确定税收允许绕过G1/S DNA损伤引起的细胞周期检查点的机制。 (2)确定在存在DNA损伤的情况下S相进入的后果。 (3)确定税收对突变频率和细胞转化的影响。这些研究的结果将在HTLV-I转化的特定过程中定义关键步骤,并可能提供对细胞增殖和转化机制的更广泛见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

SUSAN J MARRIOTT的其他基金

Development of a Novel Mouse Model to Evaluate HTLV Tax Transformation
开发新的小鼠模型来评估 HTLV 税收转型
  • 批准号:
    8637946
    8637946
  • 财政年份:
    2013
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
Development of a Novel Mouse Model to Evaluate HTLV Tax Transformation
开发新的小鼠模型来评估 HTLV 税收转型
  • 批准号:
    8488975
    8488975
  • 财政年份:
    2013
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
Transforming Potential of Emerging Human Retroviruses
新兴人类逆转录病毒的转化潜力
  • 批准号:
    7455693
    7455693
  • 财政年份:
    2008
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
Transforming Potential of Emerging Human Retroviruses
新兴人类逆转录病毒的转化潜力
  • 批准号:
    7690756
    7690756
  • 财政年份:
    2008
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    7350884
    7350884
  • 财政年份:
    1999
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    7213356
    7213356
  • 财政年份:
    1999
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    6876139
    6876139
  • 财政年份:
    1999
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
MECHANISM OF CELLULAR TRANSFORMATION BY HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    6150322
    6150322
  • 财政年份:
    1999
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
MECHANISM OF CELLULAR TRANSFORMATION BY HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    2849538
    2849538
  • 财政年份:
    1999
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
Mechanisms of Cellular Transformation by HTLV-1 TAX
HTLV-1 TAX 的细胞转化机制
  • 批准号:
    7052067
    7052067
  • 财政年份:
    1999
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:

相似国自然基金

细胞核Profilin1参与DNA复制及损伤修复在抑制乳腺癌发生中的作用及机制
  • 批准号:
    82203301
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
细胞核Profilin1参与DNA复制及损伤修复在抑制乳腺癌发生中的作用及机制
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
靶向PI3K p110β通过干扰DNA复制与损伤修复通路增强PARP抑制剂对卵巢癌细胞的杀伤作用与分子机制研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    24 万元
  • 项目类别:
    青年科学基金项目
基因组水平上DNA复制对核苷酸切除修复的影响研究
  • 批准号:
    31870804
  • 批准年份:
    2018
  • 资助金额:
    59.0 万元
  • 项目类别:
    面上项目
DNA损伤修复在非小细胞肺癌EGFR-TKI获得性耐药的分子机制研究
  • 批准号:
    81802283
  • 批准年份:
    2018
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Biochemistry of Eukaryotic Replication Fork and DNA Repair
真核复制叉的生物化学和 DNA 修复
  • 批准号:
    10550045
    10550045
  • 财政年份:
    2023
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
Impact of ATR's role in translesion synthesis on prevention of DNA damage induced mutagenesis and chromosomal instability
ATR 在跨损伤合成中的作用对预防 DNA 损伤诱导的突变和染色体不稳定性的影响
  • 批准号:
    10634852
    10634852
  • 财政年份:
    2023
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
XRN2-DDX23 Cooperation in Avoiding R-loop-induced Genomic Instability
XRN2-DDX23 合作避免 R 环引起的基因组不稳定
  • 批准号:
    10654331
    10654331
  • 财政年份:
    2023
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
Chromatin State Alterations in Fanconi Anemia Hematologic Disease and Bone Marrow Failure
范可尼贫血血液疾病和骨髓衰竭中的染色质状态改变
  • 批准号:
    10735366
    10735366
  • 财政年份:
    2023
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别:
Aging induced DNA double-strand break analysis in yeast
酵母中衰老诱导的 DNA 双链断裂分析
  • 批准号:
    10605475
    10605475
  • 财政年份:
    2023
  • 资助金额:
    $ 28.29万
    $ 28.29万
  • 项目类别: